Delivery Order SPE2DB22D3301-SPE2DB24FZ0YE

Award Date 7/18/24
Potential Completion Date 7/19/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of REFRESH PLUS 0.5% EYE DROPS 30S. The contract has a ceiling value of $2,717.51 and a completion date of July 22, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has extensive experience in providing pharmaceutical and medical products to various federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies, with a ceiling value of $1,921.45 and a completion date of January 27, 2025. The contract is a firm fixed-price delivery order type, with no set-aside designation. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $6,377.97. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" and has a firm fixed price pricing type. The ultimate completion date is May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,905.90 contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S" pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Plus 0.5% eye drops. The contract has a ceiling value of $1,206.20 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution network, will provide these medical supplies to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S". The award, with a ceiling value of $1,272.12, is under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order has a firm fixed...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,499.95, is for the supply of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S". The award, valued at $2,023.45, is a firm fixed-price contract that runs through August 8, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various government agencies, including the DLA, through its extensive federal...
This is a $1,595.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S", a type of prescription eye drops. The contract has a completion date of July 18, 2024 and does not utilize a set-aside designation. As a leading supplier of pharmaceutical and medical products to the federal government, AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S". The contract has a ceiling value of $2,205.07 and an ultimate completion date of December 20, 2024. It is a firm-fixed-price contract, which indicates a predetermined price for the goods or services provided. The contract does not have a set-aside designation, suggesting it was awarded...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ0YE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S." The contract has a ceiling value of $3,097.72 and a period of performance through July 19, 2024. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen, through its Corporate Office division, is responsible for delivering the requested eye drops to support federal healthcare programs and military treatment facilities. This award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of pharmaceutical and medical supplies to the U.S. government.

Generated 10/17/24, 9:31 AM